Go to the profile of Fate Therapeutics

Fate Therapeutics

 

About Fate Therapeutics

We are a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. Our pipeline is comprised of cell-based therapies for cancer and immune disorders. Our cellular immunotherapies are based on our novel ex vivo cell programming approach, which we apply to modulate the therapeutic function and direct the fate of hematopoietic cells.

Therapeutic Areas

Autoimmune disorders Oncology

Technologies

Other

Company Type

Other

State of Ownership

Private

Sponsorship Group

Networker

Influencer Of

Topics

Topics contributed to:

Oncology

Editions participated in:

June 2017 November 2017